Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01977859 · ClinicalTrials.gov registry record · Phase 1
BNP Pharmacodynamics and Effects on Metabolism in Lean and Obese Subjects
A Phase 1 study, sponsored by AdventHealth Translational Research Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 4
- Enrollment target
NCT01977859 is a Phase 1 study that has completed, run by AdventHealth Translational Research Institute. The registered enrollment target is 4 participants.
The verdict
NCT01977859, a Phase 1 study, has completed, sponsored by AdventHealth Translational Research Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to collect data to help researchers better understand the various causes of obesity, which may lead to the development of new obesity treatment options.
Interventions
- DRUG Saline
- DRUG Nesiritide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2013-11 |
| Est. Completion | 2017-02-28 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01977859
The ClinicalTrials.gov registry entry for NCT01977859 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AdventHealth Translational Research Institute, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Saline is the first listed.
NCT01977859 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01977859 about?
NCT01977859 is a clinical study titled "BNP Pharmacodynamics and Effects on Metabolism in Lean and Obese Subjects". The purpose of this study is to collect data to help researchers better understand the various causes of obesity, which may lead to the development of new obesity treatment options.
What is the current status of trial NCT01977859?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 4 participants. The study started on 2013-11. Estimated completion is 2017-02-28.
What interventions are being tested in trial NCT01977859?
The interventions under investigation include: Saline (DRUG), Nesiritide (DRUG).
Who is sponsoring clinical trial NCT01977859?
This trial is sponsored by AdventHealth Translational Research Institute, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.